Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications – Medical Xpress

Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications  Medical Xpress

Envirotainer expands cold chain solutions portfolio to cover all pharma segments, sizes and temperatures

The specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain portfolio.

Ozempic users say their exes are attempting to reconnect with them after weight loss: ‘Second chance at love’ – New York Post

Ozempic users say their exes are attempting to reconnect with them after weight loss: ‘Second chance…

Vori Health secures $53m funding to support musculoskeletal care

Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care…

Understanding GLP-1: The Key to Managing Blood Sugar

Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in glucose metabolism and appetite…

Unlocking the Potential of GLP-1 for Improved Health

Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in glucose metabolism and appetite…

Roche Inks ‘The Largest Obesity Deal To Date’ With Zealand Pharma At $5.3 Billion – Investor’s Business Daily

Roche Inks ‘The Largest Obesity Deal To Date’ With Zealand Pharma At $5.3 Billion  Investor’s Business Daily

Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly – Investopedia

Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly  Investopedia

Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs – Benzinga

Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs  Benzinga

What are the other health benefits weight-loss drugs may offer? – TODAY

What are the other health benefits weight-loss drugs may offer?  TODAY